Less Ads, More Data, More Tools Register for FREE

Pin to quick picks61ZU.L Regulatory News (61ZU)

  • There is currently no data for 61ZU

Form 8.3 - WYG PLC

20 May 2019 18:04

RNS Number : 6175Z
Royal Bank of Scotland Group PLC
20 May 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Royal Bank of Scotland Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

NatWest Markets Plc

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

WYG PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20 May 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p convertible shares

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,007,140

 

22.17

0

0.00

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

1,007,140

 

22.17

0

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

20 May 2019

Contact name:

Suzanne Davidson

Telephone number*:

0131 626 4120

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

LEI - RBSG: 2138005O9XJIJN4JPN90 LEI - NWM Plc: RR3QWICWWIPCS8A4S074

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETBRGDUGGDBGCG
Date   Source Headline
31st Jul 20203:54 pmRNSPublication of Supplementary Reg Doc & Prospectus
31st Jul 20207:00 amRNSInterim Results 2020
11th Jun 20205:15 pmRNSPublication of Supplementary Reg Doc & Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
3rd Jun 202012:51 pmRNSPublication of Final Terms
27th May 20209:44 amRNSPublication of Final Terms
20th May 20206:27 pmRNSPublication of Final Terms
18th May 202011:24 amRNSPublication of Final Terms
15th May 20202:45 pmRNSPublication of Final Terms
14th May 20201:55 pmRNSPublication of Supplementary Prospectus
13th May 20202:14 pmRNSRegistration Document and Base Prospectus
1st May 20204:24 pmRNSPublication of Suppl.Prospcts
1st May 20207:02 amRNSQ1 Interim Management Statement
15th Apr 20202:35 pmRNSAmendment of Final Terms
14th Apr 20203:07 pmRNSPublication of Final Terms
9th Apr 20204:21 pmRNSPublication of Final Terms
7th Apr 20205:59 pmRNSPublication of Final Terms
3rd Apr 202011:14 amRNSPublication of Final Terms
1st Apr 202012:48 pmRNSPublication of Final Terms
26th Mar 202010:46 amRNSPublication of Final Terms
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
16th Mar 20202:36 pmRNSPublication of Final Terms
24th Feb 20202:18 pmRNSPublication of Final Terms
17th Feb 20201:20 pmRNSPublication of Supplementary Prospectus
14th Feb 20207:03 amRNSAnnual Financial Report
14th Feb 20207:02 amRNSFinal Results
7th Jan 202011:09 amRNSPublication of Final Terms
27th Dec 201911:26 amRNSPublication of Final Terms
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20194:42 pmRNSAmendments To Provisions Relating To Interest
6th Dec 20191:16 pmRNSPublication of Final Terms
4th Dec 20192:47 pmRNSPublication of Final Terms
2nd Dec 20193:00 pmRNSPublication of Suppl.Prospcts
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
21st Nov 20196:29 pmRNSPublication of a Prospectus
19th Nov 20192:33 pmRNSPublication of Final Terms
4th Nov 201912:55 pmRNSPublication of Final Terms
25th Oct 20194:51 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:01 amRNSQ3 Interim Management Statement
18th Oct 20192:50 pmRNSNotice of Redemption
4th Oct 20191:30 pmRNSPublication of Final Terms
13th Sep 20193:53 pmRNSPublication of Final Terms
28th Aug 20192:48 pmRNSPublication of Final Terms
2nd Aug 20192:47 pmRNSPublication of Supplementary Prospectus
2nd Aug 20197:01 amRNSInterim Results 2019
3rd Jul 20195:03 pmRNSPublication of Final Terms
2nd Jul 201912:02 pmRNSPublication of Supplementary Reg Doc & Prospectus
28th Jun 20192:45 pmRNSDividend Declaration
26th Jun 201912:32 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.